http://www.inveslogic.com/popular/articles/biotechnology Biotechnology - Today's Popular Articles at http://www.inveslogic.com en http://www.inveslogic.com/sectors/directory/etf-investor/1119419?rsstype=populararticles&cid=12 US non-farm payrolls data was bad, quite bad, but not terribly bad. When the US economy is in such a bad state, it takes quite a lot to shock. Anyway here are the numbers: The US unemployment rate unexpectedly jumped to 6.1% in August from 5.7% in Ju... Fri, 05 Sep 2008 15:34:15 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119419?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1119350?rsstype=populararticles&cid=12 Now that the Republican and Democratic conventions are behind us, I m planning to write a series of posts to provide my perspective on the candidates health care proposals. I ll follow the framework laid out by the Kaiser Family Foundation s... Fri, 05 Sep 2008 10:54:49 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1119350?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119261?rsstype=populararticles&cid=12 Genomic Health Inc. (GHDX)Q2 2008 Earnings Call Transcript... Fri, 05 Sep 2008 10:03:15 -0400 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119261?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1119237?rsstype=populararticles&cid=12 Today s ration of scientific confusion comes courtesy of Wired, in an article that talks about using a modified form of TMV (tobacco mosaic virus) for delivering silencing RNAs. A group at Maryland has used the virus to deliver various siRNAs to ce... Fri, 05 Sep 2008 08:27:30 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1119237?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1119197?rsstype=populararticles&cid=12 Below we highlight our trading range charts of the S&P 500 and its ten sectors. In the charts below, the blue shading represents between one standard deviation above and below the 50-day moving average (white line). When prices are within this bl... Fri, 05 Sep 2008 08:22:47 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119197?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1119198?rsstype=populararticles&cid=12 While reading through a summary of the August auto sales numbers I began to think about the need for a better set of metrics to gauge the monthly sales performance of auto makers (from one year to the next and in comparison to each other), because th... Fri, 05 Sep 2008 08:16:55 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119198?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1119201?rsstype=populararticles&cid=12 From the Wall Street JournalU.S. v. Philip Morris: Topping the list is United States v. Philip Morris, an appeal of the decade-long civil racketeering case against the tobacco industry. Philip Morris, now known as Altria Group (MO), is challenging ... Fri, 05 Sep 2008 08:08:36 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119201?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119264?rsstype=populararticles&cid=12 Medivation's Presentation: Standing Room Only A little more than 24 hours after announcing its big, lucrative Alzheimer's drug partnership with Pfizer (PFE), Medivation (MDVN)had the lead-off position (I wonder if they told organizers they'd be a new... Fri, 05 Sep 2008 04:12:14 -0400 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1119264?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1119141?rsstype=populararticles&cid=12 Genesis Pharmaceuticals Enterprises (GNPH.OB) has effected a 40-to-1 reverse stock split and changed its ticker symbol to GNPH from the previous symbol GTEC. As before, Genesis Pharma trades on the OTC Bulletin Board Exchange. After the reverse split... Fri, 05 Sep 2008 03:09:43 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119141?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1119147?rsstype=populararticles&cid=12 It s hard to read the WSJ these days without hearing something about buybacks. Exxon (XOM) absorbing $102 billion, Citigroup (C) spending $8.3 billion and even Coach (COH) buying back $1 billion. Stock buybacks or share repurchases are known to ... Fri, 05 Sep 2008 02:17:24 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1119147?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118932?rsstype=populararticles&cid=12 One of the next big checkpoints on the health of the enterprise tech sector will come September 18, when Oracle (ORCL) posts results for its fiscal first quarter ended August. And the Street is getting a wee bit nervous. JMP Securities analyst Patri... Thu, 04 Sep 2008 15:55:15 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118932?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118830?rsstype=populararticles&cid=12 Excerpts from Hallgarten & Company's recent 'Metals Outlook' report by Christopher Ecclestone: ... Thu, 04 Sep 2008 10:39:16 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118830?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1118753?rsstype=populararticles&cid=12 X-ray crystallography is wonderful stuff I think you ll get chemists to generally agree on that. There s no other technique that can provide such certainty about the structure of a compound and for medicinal chemists, it has the invaluabl... Thu, 04 Sep 2008 08:41:13 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1118753?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118711?rsstype=populararticles&cid=12 The Wall Street Journal Price Strategy Puts WellPoint in Bind reports that the CEO of America s largest health insurer, Angela Braly, is having difficulty balancing shareholders' need for profits with unaffordable premiums. To cope with ris... Thu, 04 Sep 2008 08:09:32 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118711?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118743?rsstype=populararticles&cid=12 Check out the latest edition of the Health Wonk Review at InsureBlog.... Thu, 04 Sep 2008 07:48:51 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118743?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118722?rsstype=populararticles&cid=12 Just on the horizon with a declining price trendline is Nucor (NUE). NUE is described by Mergent Online as a company that, ...produces and sells steel and steel products via its steel mills and steel products segment. As of today, NUE is within ... Thu, 04 Sep 2008 06:56:17 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118722?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118724?rsstype=populararticles&cid=12 When people begin anticipating inflation, it doesn't do you any good anymore, because any benefit of inflation comes from the fact that you do better than you thought you were going to do. Paul A. Volcker When the Commerce Department released its... Thu, 04 Sep 2008 06:42:24 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118724?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118732?rsstype=populararticles&cid=12 The reality is that each second, we all get older. All the money in the world will not turn back the inevitable biological clock. This fact doesn't stop millions of baby-boomers from trying, however. This is obvious by the amount of plastic surgery, ... Thu, 04 Sep 2008 06:01:52 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118732?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118618?rsstype=populararticles&cid=12 In late July at a big scientific conference in Chicago, I reported on new, positive data on Medivation's (MDVN) experimental Alzheimer's drug Dimebon (dim-uh-bahn). In addition to the rest results being compelling, I highlighted the drug because it h... Thu, 04 Sep 2008 03:49:49 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118618?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118744?rsstype=populararticles&cid=12 California is considering imposing a mandatory minimum Medical Loss Ratio (MLR) on health plans operating in the state. The law would require health plans to spend at least 85 percent of their premium revenue on medical care. Backers say it would kee... Wed, 03 Sep 2008 22:18:21 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118744?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1118346?rsstype=populararticles&cid=12 It s a truism that half of all advertising dollars are wasted, but that no one buying the ads can be sure which half it is. Advertising from the drug companies is ubiquitous: how much of that is doing them no good?A recent study suggests that the w... Wed, 03 Sep 2008 10:00:30 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1118346?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1118320?rsstype=populararticles&cid=12 Are we there yet? Clearly there are signs of sector rotation. This chart from the WSJ shows money has been flying out of Energy and Materials in July and August and moving into Consumer Discretionary, Health Care, Consumer Staples and Financials bu... Wed, 03 Sep 2008 09:55:24 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1118320?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118745?rsstype=populararticles&cid=12 CNN s Five mistakes that will land you in medical debt provides good advice to those who end up with big medical bills. Here are the mistakes they highlight:You ignore your bills and end up hounded by a collection agencyYou don t look for erro... Tue, 02 Sep 2008 15:53:08 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118745?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117928?rsstype=populararticles&cid=12 Pharmaceutical companies are trading well below their historical P/E levels. To anyone who follows the industry, this comes as no surprise. After a slew of blockbuster drugs that hit the market several years ago, the R&D departments of the largest co... Tue, 02 Sep 2008 14:33:19 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117928?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117791?rsstype=populararticles&cid=12 Markets were generally higher during the month of August with the broad Russell 3000 Index climbing by 1.5%. Much like July, we saw a reversal of what we saw in the first half of the year with sectors that were generally strong in the first half of t... Tue, 02 Sep 2008 10:47:17 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117791?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117807?rsstype=populararticles&cid=12 A yield curve is the relationship between yield and maturity. In a normal yield curve yields rise as maturity lengthens. When yields drop as the term lengthens, it is referred to as an inverted yield curve. A Yield On Cost (current dividend/basis) ... Tue, 02 Sep 2008 10:01:57 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117807?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117648?rsstype=populararticles&cid=12 Shionogi & Co. (SGIOF.PK), a major Japanese drug manufacturer and US-based specialty pharmaceutical company Sciele Pharma, Inc. (SCRX), announced on Monday a definitive agreement under which Shionogi will acquire Atlanta-based Sciele Pharma Inc. shar... Tue, 02 Sep 2008 07:39:55 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117648?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117543?rsstype=populararticles&cid=12 Checking on the biotechnology sector, we spoke with Zacks senior analyst Grant Zeng, CFA about recent developments among these companies. We discussed M&A [mergers and acquisitions] activity as well as top Buy recommendations. How has earnings season... Tue, 02 Sep 2008 03:31:52 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117543?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117389?rsstype=populararticles&cid=12 Investing in biotech can be incredibly exciting and rewarding. After all, there's nothing like getting in early on a company with a novel drug for cancer, diabetes or any other debilitating disease - watching the drug successfully navigate clinical t... Mon, 01 Sep 2008 06:57:02 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117389?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117319?rsstype=populararticles&cid=12 Last week s news from the China biomedical world started off with a flurry of announcements that were unusual in their uniformity: each centered on the subject of Deals and Financings. As the week progressed, the news developed a greater diversity ... Mon, 01 Sep 2008 03:27:44 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117319?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117322?rsstype=populararticles&cid=12 The market for hepatitis B drugs in China is expected to grow 135% by 2012, according to a new report from Decision Resources. From $340 million in 2007, sales of hepatitis B treatments will increase to $800 million over the five years, a CAGR of 18%... Mon, 01 Sep 2008 03:17:46 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117322?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1117054?rsstype=populararticles&cid=12 I recently purchased a starter position in the Nuveen Floating Rate Income Fund (JFR). The fund invests 65% of its assets in adjustable rate senior loans secured by specific collateral and at least 80% in secured and unsecured adjustable rate senior ... Sun, 31 Aug 2008 04:13:45 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1117054?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/biotech-weblog/1117457?rsstype=populararticles&cid=12 Photo courtesy of iStockphoto, Image# 4790813In a trial involving sets of twins, a study published in Phytotherapy Research suggests that a 1000mg of a specific olive leaf extract (EFLA 943, Trademark: Benolea) can lower cholesterol and lower blood ... Sat, 30 Aug 2008 10:22:26 -0400 http://www.inveslogic.com/sectors/directory/biotech-weblog/1117457?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1116780?rsstype=populararticles&cid=12 Currently, 64% of stocks in the S&P 500 are trading above their 50-day moving averages. As shown in the chart below, the reading has been creeping higher and higher since mid-July, and looks to be on its way to the 80%-85% levels seen twice over th... Fri, 29 Aug 2008 15:45:32 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1116780?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118747?rsstype=populararticles&cid=12 The Wall Street Journal (Glaxo s HIV-Drug Ads Draw Critics) and Wall Street Journal Health Blog (Are Ads for HIV Drugs Too Scary?) wrote earlier this week about consumer-directed advertising for HIV drugs from GlaxoSmithKline (GSK) and Bristol-Myer... Fri, 29 Aug 2008 12:08:55 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118747?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1116691?rsstype=populararticles&cid=12 In the current monster-sized issue of Vogue, my producer, Ruth, while killing time on the Delta shuttle on our way from New York to Boston for a shoot this week, uncovered a blogworthy story buried in the hundreds and hundreds and hundreds of pages o... Fri, 29 Aug 2008 09:15:43 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1116691?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1116566?rsstype=populararticles&cid=12 Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility. Adefovir dipivoxil, the drug newly approved for mar... Fri, 29 Aug 2008 07:25:00 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1116566?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118749?rsstype=populararticles&cid=12 Regular readers remember last year s Avastin/Lucentis debate here on the Health Business Blog. To recap: the drugs are essentially the same and they re made by the same company. Avastin is a cancer drug and Lucentis is used in the eye. Compoundin... Thu, 28 Aug 2008 15:18:23 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118749?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116057?rsstype=populararticles&cid=12 Within a 12-hour period five biopharma companies revealed negative drug news that is sending their stocks lower -- in the case of Amylin Pharmaceuticals (AMLN) and Cell Genesys (CEGE), much lower.After the closing bell Tuesday, Bristol-Myers Squibb (... Thu, 28 Aug 2008 03:32:54 -0400 http://www.inveslogic.com/sectors/directory/seeking-alpha-biotech-stocks/1116057?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118750?rsstype=populararticles&cid=12 The distribution of prescription pharmaceuticals is beginning to take on some of the characteristics of online videos and music. Traditionally, access to prescriptions works as follows:Patient has a problemPatients sees his/her physicianPhysician dia... Wed, 27 Aug 2008 21:21:53 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118750?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1115928?rsstype=populararticles&cid=12 As Arthur Kornberg never tired of pointing out, cells are gels. It s too easy for biologists and chemists to imagine cells as sort of like liquid-filled plastic bags and while that s an OK picture as far as it goes, it tends to make you pictu... Wed, 27 Aug 2008 08:31:10 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1115928?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/biotech-weblog/1117459?rsstype=populararticles&cid=12 Photo courtesy of iStockphoto, Andrejs ZemdegaResearchers have shown that a gene called FRO7 is vital for efficient photosynthesis and for iron metabolism, processes necessary for producing a healthy plant and a nutritious food source.In this study, ... Wed, 27 Aug 2008 08:09:43 -0400 http://www.inveslogic.com/sectors/directory/biotech-weblog/1117459?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1115660?rsstype=populararticles&cid=12 Statement From Senator Obama on the Census Income, Health Insurance and Poverty NumbersToday s news confirms what America s struggling families already know that over the past seven years our economy has moved backwards. We have now lived thr... Tue, 26 Aug 2008 20:30:59 -0400 http://www.inveslogic.com/sectors/directory/a-canadian-econoview/1115660?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118751?rsstype=populararticles&cid=12 Disease management company Healthways reported weak earnings yesterday and the stock dropped more than 20 percent, to about $20 per share. Forbes.com s article on the the news relies exclusively on Jeffries Analyst Arthur Henderson as its expert... Tue, 26 Aug 2008 15:07:20 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118751?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/health-business-blog/1118752?rsstype=populararticles&cid=12 Check out the latest edition of the Health Wonk Review at Workers Comp Insider.... Tue, 26 Aug 2008 13:18:54 -0400 http://www.inveslogic.com/sectors/directory/health-business-blog/1118752?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/biotech-weblog/1115425?rsstype=populararticles&cid=12 Photo courtesy of iStockphoto, Stephanie Horrocks Researchers have designed a nano-sized trojan horse particle to aid in the absorption of antioxidants in the gut by protectin antioxidants from enzyme and acid breakdown.The solution is to design a ... Tue, 26 Aug 2008 10:56:46 -0400 http://www.inveslogic.com/sectors/directory/biotech-weblog/1115425?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1115331?rsstype=populararticles&cid=12 Prices of Treasury coupon securities are registering small mixed changes in overnight trading. The gloom which hung over the US markets yesterday remains today and motivated trading in foreign markets. Asian equities fell in sympathy with the steep d... Tue, 26 Aug 2008 09:32:45 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1115331?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1115370?rsstype=populararticles&cid=12 As all organic chemists who follow the literature know, over the last few years there s been a strong swell of papers using Barry Sharpless s click chemistry triazole-forming reactions. These reaction let you form five-membered triazole rin... Tue, 26 Aug 2008 08:37:06 -0400 http://www.inveslogic.com/sectors/directory/in-the-pipeline/1115370?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/etf-investor/1115348?rsstype=populararticles&cid=12 The Wall Street Journal Blue Cross Plans Feeling Pressure to Consolidate reports that Pennsylvania s two largest non-profit Blue Cross plans are seeking regulatory approval to merge and New Jersey s largest health insurer filed an applicati... Tue, 26 Aug 2008 08:07:41 -0400 http://www.inveslogic.com/sectors/directory/etf-investor/1115348?rsstype=populararticles&cid=12 http://www.inveslogic.com/sectors/directory/biotech-weblog/1115293?rsstype=populararticles&cid=12 Photo courtesy of iStockphoto, Grigory Bibikov Research findings lead by Prof. Eliezer Flescher of The Sackler Faculty of Medicine, Tel Aviv University reported that a compound derived from the jasmine flower could be the key to a new effective thera... Tue, 26 Aug 2008 06:50:33 -0400 http://www.inveslogic.com/sectors/directory/biotech-weblog/1115293?rsstype=populararticles&cid=12